Center for Health Policy and Research; Clinical Pharmacy Services; Commonwealth Medicine
Female Urogenital Diseases and Pregnancy Complications | Health Economics | Health Services Administration | Health Services Research | Maternal and Child Health | Obstetrics and Gynecology | Pharmacy and Pharmaceutical Sciences
An analysis of medication adherence and birth outcomes among members receiving progesterone for the prevention of preterm birth in a state Medicaid program. Data is also used to evaluate the association between member characteristics and medication adherence and birth outcomes as well as whether there was a change in the cost of care.
preterm birth, progesterone, medication adherence, birth outcomes, cost of care, Medicaid, MassHealth, Massachusetts
Rights and Permissions
© 2017 University of Massachusetts Medical School
2017 American Drug Utilization Review Society
Hydery, Tasmina; Price, Mylissa K.; Greenwood, Bonnie C.; Takeshita, Mito; Mauro, Rose; Kunte, Parag; Lenz, Kimberly J.; and Jeffrey, Paul L., "Evaluation of Progesterone Agent Utilization and Birth Outcomes in a State Medicaid Plan" (2017). Commonwealth Medicine Publications. 36.
Female Urogenital Diseases and Pregnancy Complications Commons, Health Economics Commons, Health Services Administration Commons, Health Services Research Commons, Maternal and Child Health Commons, Obstetrics and Gynecology Commons, Pharmacy and Pharmaceutical Sciences Commons